Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Spirapril

An antihypertensive ACE inhibitor patented in 1980 and approved for medical use in 1995: it is a prodrug that the body converts into its active form, spiraprilat. This family brings together the active ingredient.

Did you know?Unlike most ACE inhibitors it is eliminated by both the kidneys and the liver; its molecule contains an unusual spiro ring with two sulfur atoms.

Spirapril Hydrochloride MonohydrateGo to the active ingredient →

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.